Cocrystal Pharma Inc expected to post a loss of 16 cents a share - Earnings Preview
Cocrystal Pharma Inc <COCP.OQ> expected to post a loss of 16 cents a share - Earnings Preview
Cocrystal Pharma Inc COCP.OQ COCP.O is expected to show no change in quarterly revenue when it reports results on August 12 (estimated) for the period ending June 30 2026
LSEG's mean analyst estimate for Cocrystal Pharma Inc is for a loss of 16 cents per share.
The one available analyst rating on the shares is "buy".
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Cocrystal Pharma Inc is $9.00, about 749.1% above its last closing price of $1.06
This summary was machine generated August 10 at 13:19 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
Recent news on Cocrystal Pharma
See all newsBrief: Cocrystal Pharma Announces Last Subject Dosed In Phase 1b Human Challenge Study Evaluating CDI-988 For Norovirus Prevention And Treatment
Cocrystal Pharma Inc reports results for the quarter ended June 30 - Earnings Summary
Cocrystal Pharma Inc expected to post a loss of 16 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Medtronic, Macy's, USA Rare Earth
U.S. STOCKS ON THE MOVE-USA Rare Earth, MiniMed, Rent the Runway